Kevin Kotler

Kevin Kotler

Directeur Général chez Broadfin Capital LLC

Fortune : 75 M $ au 30/04/2024

53 ans
Finance
Health Technology
Consumer Services

Profil

Mr. Kevin Kotler is an Independent Director at BioDelivery Sciences International, Inc., a Managing Partner & Portfolio Manager at Broadfin Capital LLC and a Principal at Broadfin Healthcare Fund LP.
He is on the Board of Directors at Avadel Pharmaceuticals Plc, BioDelivery Sciences International, Inc., InnerSpace Neuro Solutions, Inc. and Broadfin Healthcare Offshore Fund Ltd.
He has over 24 years of experience as an investor in the medical technology industry.
Mr. Kotler began his investment career as a Research Associate at Furman Selz (1993-1994) and moved to UBS as a junior medical technology and supplies analyst (1994-1998) focusing on small capitalization companies across a number of medical specialties.
From UBS, he moved to ING (1998-2002), where he assumed greater responsibility as a senior medical technology and supplies analyst.
He continued with ING through its acquisition by ABN AMRO and remained there until he was recruited to The Galleon Group (2002-2005) where he ran a healthcare carve out and was a research analyst in the Firm’s healthcare fund.
In July 2005, he left to form Broadfin Capital.
He graduated from the Wharton School at the University of Pennsylvania in 1993 with a Bachelor of Science degree in Economics.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
12/02/2024 3 716 242 ( 4,10% ) 66 M $ 30/04/2024
27/03/2024 1 899 930 ( 6,30% ) 7 M $ 30/04/2024
18/04/2023 540 000 ( 0,36% ) 1 M $ 30/04/2024

Postes actifs de Kevin Kotler

SociétésPosteDébut
Directeur Général 01/06/2005
Corporate Officer/Principal -
Directeur/Membre du Conseil 23/04/2009
Directeur/Membre du Conseil 01/01/2014
Curonix Directeur/Membre du Conseil -
Tous les postes actifs de Kevin Kotler

Anciens postes connus de Kevin Kotler

SociétésPosteFin
HERON THERAPEUTICS, INC. Directeur/Membre du Conseil 31/12/2023
BIODELIVERY SCIENCES INTERNATIONAL, INC. Directeur/Membre du Conseil 22/03/2022
AVADEL PHARMACEUTICALS PLC Directeur/Membre du Conseil 01/10/2019
NOVELION THERAPEUTICS INC. Directeur/Membre du Conseil 24/09/2018
░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Kevin Kotler

Formation de Kevin Kotler

University of Pennsylvania Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kevin Kotler

Relations

100 +

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
HERON THERAPEUTICS, INC.

Health Technology

AVADEL PHARMACEUTICALS PLC

Health Technology

Entreprise privées11

Finance

Health Technology

Finance

Finance

Finance

Furman Selz LLC

Finance

Finance

Electronic Technology

Health Technology

Hamptons

Curonix

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Kevin Kotler